AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2020
May 8, 2020
30016_dirs_2020-05-08_9fcde542-9149-4607-b0ab-3f90527d7c6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-05-06
Reporting Person: Vandebroek Sophie V. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-06 | Deferred Stock Unit | $ | A | 370 | Acquired | Common Stock (370) | Direct | |
| 2020-05-06 | Non-Qualified Stock Option (right-to-buy) | $283.59 | A | 1279 | Acquired | 2030-05-05 | Common Stock (1279) | Direct |
Footnotes
F1: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.
F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event is earlier.
F3: Not applicable.